Ligand profile
ZINC1399281
Virtual-screening candidate from ZINC.
Bound to: VK055_1374 — 3-oxoacyl-[acyl-carrier-protein] reductase
Identifiers
Database identifiers and provenance.
- Ligand ID
ZINC1399281- UniProt (similar protein)
O54438- Tanimoto
- 1.000
- Target protein
- VK055_1374
Structure
2D representation rendered from SMILES.
Physicochemical properties
Computed with RDKit from SMILES.
Drug-likeness
Descriptor-based ADME screening flags from SMILES. These are not experimental toxicity results.
Estimated from TPSA and LogP only: TPSA ≤ 90 Ų and −1 ≤ LogP ≤ 5 are treated as a favorable small-molecule permeability screen.
- TPSA ≤ 90 Ų 38.2
- −1 ≤ LogP ≤ 5 3.19
- MW ≤ 500 Da 297.4
- LogP ≤ 5 3.19
- H-bond donors ≤ 5 0
- H-bond acceptors ≤ 10 5
- Rotatable bonds ≤ 10 2
- TPSA ≤ 140 Ų 38.2
No PAINS structural alerts detected.
Chemical representations
Canonical representations for cheminformatics workflows.
c1ccc(-c2nc(N3CCOCC3)c3sccc3n2)cc1c1ccc(-c2nc(N3CCOCC3)c3sccc3n2)cc1
InChI=1S/C16H15N3OS/c1-2-4-12(5-3-1)15-17-13-6-11-21-14(13)16(18-15)19-7-9-20-10-8-19/h1-6,11H,7-10H2InChI=1S/C16H15N3OS/c1-2-4-12(5-3-1)15-17-13-6-11-21-14(13)16(18-15)19-7-9-20-10-8-19/h1-6,11H,7-10H2
RBDRSWPTRGNKIG-UHFFFAOYSA-NRBDRSWPTRGNKIG-UHFFFAOYSA-N
Provenance
Annotation context from LigQ_2, the internal Target step that collects PDB, ChEMBL, and ZINC ligand evidence.
- Method
- LigQ nearest_k
- Query
- 36I
- Homolog
- O54438
External resources
Open this ligand in third-party databases and cheminformatics tools.
- ZINC ZINC15 ZINC1399281 →
- ZINC ZINC20 ZINC1399281 →
- UniProt UniProt O54438 (homolog) →
- PubChem PubChem (by InChIKey) →
- Cheminformatics SwissADME prediction →
- Cheminformatics SwissTargetPrediction →
- Web Google Scholar (search “ZINC1399281”) →
Other ligands for this protein
Quick navigation to other ligands bound to VK055_1374.
PDB 18
Ligands co-crystallized with this protein (structural evidence).
ChEMBL 5
Compounds with measured inhibitory activity on this target (higher pchembl = more potent).
ZINC 49
Virtual screening candidates selected by structural similarity to known actives (Tanimoto ≥ 0.5).